Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors | MicrobiomeTrials← Back to trialsNCT03739827
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
RecruitingOBSERVATIONAL
Trial Details
Start: 2019-01-28Est. Completion: 2028-05-31
Enrollment target: 10,000 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- Oregon Health and Science University, Portland, Oregon, United States
- Texas Children's Hospital, Houston, Texas, United States
Other microbiome trials you might be interested in
Solid TumorHealthyMalignant Solid Neoplasm
The purpose of this study is to understand how the body's immune cells respond to a new type of vaccine (neoantigen vacc…
Jacksonville, United StatesEst. completion Oct 31, 2028
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IIB Cutaneous Melanoma AJCC v8Clinical Stage IIC Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Esophageal CarcinomaGastroesophageal Junction AdenocarcinomaHepatocellular CarcinomaLocally Advanced Urothelial CarcinomaLung Non-Small Cell CarcinomaMalignant Solid NeoplasmMetastatic Colorectal CarcinomaMetastatic Cutaneous MelanomaMetastatic Esophageal Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Urothelial CarcinomaRecurrent Esophageal Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRenal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage IV Renal Cell Cancer AJCC v8Unresectable Cutaneous MelanomaUnresectable Esophageal Squamous Cell CarcinomaUrothelial CarcinomaUnresectable Urothelial Carcinoma
This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setti…
Jacksonville, United StatesEst. completion Dec 31, 2026
Hematopoietic and Lymphoid System NeoplasmMetastatic Malignant Solid Neoplasm
This study characterizes deoxyribonucleic acid (DNA) and proteomic (protein) changes in both biopsies and tumors removed…
Rochester, United StatesEst. completion Apr 30, 2031